Megan is the Director of Operations within the Research, Innovation and Commercialisation (RIC) at the University of Melbourne. RIC is the central facilitator of all research and commercial income for the University, currently valued at more than $400 million.

Megan has over 20 years’ senior management experience in technology organisations in both the private and public sectors, with a focus on technology management and commercialisation. Prior to her current role, she worked at CSIRO in senior Business Development and Commercialisation (BDC) leadership roles. Megan’s most recent role at CSIRO was Executive Manager of BDC, leading teams responsible for business development and commercial activities across four CSIRO business units (Manufacturing, Digital Productivity, Minerals Resources and CSIRO Services) with a significant intellectual property portfolio and revenue of $110 million.

At CSIRO Megan was a key driver and negotiator in the commercialisation of major intellectual property transactions, including spin-outs and licensing with local and global companies. Megan has been a CSIRO customer lead for a number of large multinational companies that include DuPont and Procter & Gamble. She was a board member of Intalysis and the CRC for Polymers and was a member of the Stakeholder Insight Group for PACIA.

Prior to joining CSIRO, Megan was a member of the senior management team of the Australian biotech Progen Pharmaceuticals Limited (listed on both the ASX and the NASDAQ). She held several roles at Progen, including Vice President of Business Development and Sales and Marketing Manager, where she was responsible for the local and international marketing of a range of life science research products. Her first role with Progen was as Research and Development Manager.

Megan graduated from the University of Sydney with a Bachelor of Science (first class honours) and a PhD in organic chemistry. She has an MBA from the Queensland University of Technology.